Long, Jeffrey D. https://orcid.org/0000-0001-7181-9652
Mills, James A.
Funding for this research was provided by:
CHDI Foundation
Michael J. Fox Foundation for Parkinson's Research
National Institutes of Health
Article History
Received: 16 March 2018
Accepted: 29 October 2018
First Online: 16 November 2018
Authors’ information
: Jeffrey D. Long is a Professor in the Department of Psychiatry (primary) and the Department of Biostatistics (secondary), University of Iowa. James A. Mills is a biostatistician in the Department of Psychiatry, University of Iowa.
: Study activities were reviewed and approved by institutional review boards (PREDICT-HD) or local ethics committees (TRACK-HD, REGISTRY, Enroll-HD). Informed consent procedures were carried out for each participant, and signed consents for participation and the distribution of de-identified data for collaborative research were obtained.
: Not applicable.
: JDL is a paid consultant for Wave Life Sciences USA Inc., Vaccinex Inc., and Azevan Pharmaceuticals Inc. He is also a paid advisory board member for Wave Life Sciences USA Inc., F. Hoffmann-La Roche Ltd., Huntington Study Group (for uniQure biopharma B.V.), and Mitoconix Bio Limited.JAM is a paid consultant for Wave Life Sciences USA Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.